SGLT2 inhibitors are a class of medications primarily used to manage type 2 diabetes. They work by blocking the sodium-glucose co-transporter 2 in the kidneys, which helps to lower blood sugar levels by preventing glucose reabsorption. This results in increased glucose excretion through urine. In addition to controlling blood sugar, SGLT2 inhibitors have been shown to provide benefits for heart and kidney health. They can reduce the risk of heart failure and slow the progression of kidney disease in patients with diabetes, making them an important option in diabetes management.